Literature DB >> 3034745

Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).

J N Weber, S Thom, I Barrison, R Unwin, S Forster, D J Jeffries, A Boylston, A J Pinching.   

Abstract

Three patients with biopsy diagnosed invasive cytomegalovirus infection of the colon have been seen in the context of the acquired immune deficiency syndrome (AIDS). Cytomegalovirus colitis presented with fever, abdominal distention, bloody diarrhoea and weight loss. Plain abdominal radiographs showed generalised large bowel dilatation in one patient. Cytomegalovirus infection was shown histologically, but the virus could not be cultured from the stool; no other gastrointestinal pathogens could be demonstrated. The patients were treated with a 14 day continuous infusion of Foscarnet 0.08 mg/kg/min (phosphonoformate, Astra Pharmaceuticals). One patient showed a partial response to therapy, but the cytomegalovirus colitis relapsed; the second patient had a symptomatic response only and the third patient died of non-cytomegalovirus opportunist infection while on treatment. Two other patients with biopsy proven cytomegalovirus ulceration of the oesophagus were seen, presenting with dysphagia, fever and weight loss. Invasive infection of the gastrointestinal tract with cytomegalovirus is now a major clinical problem in AIDS. Treatment with Foscarnet may be initially effective, but does not eliminate cytomegalovirus infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034745      PMCID: PMC1432827          DOI: 10.1136/gut.28.4.482

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Death in the AIDS patient: role of cytomegalovirus.

Authors:  A M Macher; C M Reichert; S E Straus; D L Longo; J Parrillo; H C Lane; A S Fauci; A H Rook; J F Manischewitz; G V Quinnan
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

2.  Perforation of the colon associated with cytomegalovirus infection.

Authors:  Z D Goodman; J K Boitnott; J H Yardley
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

3.  Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients.

Authors:  S E Straus; M Seidlin; H Takiff; D Jacobs; D Bowen; H A Smith
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

4.  A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome.

Authors:  W R Freeman; C W Lerner; J A Mines; R S Lash; A J Nadel; M B Starr; M L Tapper
Journal:  Am J Ophthalmol       Date:  1984-02       Impact factor: 5.258

5.  Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection.

Authors:  H S Cooper; E C Raffensperger; L Jonas; W T Fitts
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

6.  Colon ulceration in lethal cytomegalovirus infection.

Authors:  E Foucar; K Mukai; K Foucar; D E Sutherland; C T Van Buren
Journal:  Am J Clin Pathol       Date:  1981-12       Impact factor: 2.493

7.  Cytomegalovirus infections in homosexual men. An epidemiological study.

Authors:  L Mintz; W L Drew; R C Miner; E H Braff
Journal:  Ann Intern Med       Date:  1983-09       Impact factor: 25.391

8.  Cytomegalovirus encephalitis in acquired immunodeficiency syndrome.

Authors:  D A Hawley; J F Schaefer; D M Schulz; J Muller
Journal:  Am J Clin Pathol       Date:  1983-12       Impact factor: 2.493

9.  Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men.

Authors:  R J Biggar; H K Andersen; P Ebbesen; M Melbye; J J Goedert; D L Mann; D M Strong
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-25

10.  Acquired immunodeficiency syndrome, opportunistic infections, and malignancies in male homosexuals. A hypothesis of etiologic factors in pathogenesis.

Authors:  J Sonnabend; S S Witkin; D T Purtilo
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

View more
  6 in total

1.  Treatment of gastrointestinal cytomegalovirus infection with twice-daily foscarnet: a pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS.

Authors:  D T Dieterich; M A Poles; E A Lew; S Martin-Munley; J Johnson; D Nix; M J Faust
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

2.  Adult acquired cytomegalovirus infection with gastric and duodenal ulceration.

Authors:  R C Spiller; D Lovell; D B Silk
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

Review 3.  Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.

Authors:  P Chrisp; S P Clissold
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

4.  Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome.

Authors:  G M Connolly; D Hawkins; J N Harcourt-Webster; P A Parsons; O A Husain; B G Gazzard
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

5.  [Diagnosis and clinical aspects of gastrointestinal cytomegalovirus diseases in patients with human immunodeficiency virus 1 infection].

Authors:  M Schrappe-Bächer; H M Steffen; G Ollenschläger; B Salzberger; G Fätkenheuer; S Degenhardt; G R Krüger
Journal:  Klin Wochenschr       Date:  1989-11-03

6.  Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS.

Authors:  N D Francis; A W Boylston; A H Roberts; J M Parkin; A J Pinching
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.